Biochemical and neurotransmitters changes associated with tramadol in streptozotocin-induced diabetes in rats.

The incidence of diabetes is increasing worldwide. Chronic neuropathic pain occurs in approximately 25% of diabetic patients. Tramadol, an atypical analgesic with a unique dual mechanism of action, is used in the management of painful diabetic neuropathy.